KIR2DL3 and systemic sclerosis: Of HLA-C*16 + individuals, 79.7% of SSc patients co-inherited KIR2DL3 relative to 90.2% of controls (OR = 0.44, p = 0.009), whereas KIR2DL3 frequencies did not differ in HLA-C*16- individuals.